Sage Therapeutics

254 people · 0 jobs
‌

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders.

Industries

Employees

501-1,000

Links


Org chart

Collapse
Anne Marie Cook
SVP & General Counsel
Marjorie Stewart-Hart (she/her)
Vice President, Patient Engagement And Advocacy
Matthew Henson
Vice President, Corporate Communications
Robert A.
Senior Vice President, Strategic Insights/analytics, Field Effectiveness, Forecasting
Sunil Chawla
Executive Director, Supply Chain
Greg Silvesti
Vice President | Digital Health & Innovation
Paul S. Watson
Vice President Head Of Pharmaceutical Development
Alexandria Costanzo (Dougherty)
Regional Business Director
Etchell Cordero
Executive Director, Business Operations
Steven Collier
Vice President Technical Operations
Jaime Koralewski
Senior Director, Quality
Ruta Sawant
Director
Claire Quam-Wickham
Director Program Management
Michael Flanagan
Vice President, Corporate Controller
Pamela Herbster
Svp, Chief People & Experience Officer
Tammy Phinney
Senior Vice President Regulatory Affairs
Becky Terry
Executive Director
Francesca Dellelci
Vice President And Head Of Corporate Communications
Jeff Kasten
Vice President, Corporate Strategy & Business Development
Theresa Vera
Executive Medical Director

Board & advisors